Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-29

Clinical Trial Update: Study to Treat Uveitis Associated Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial for treating uveitis-associated cystoid macular edema was terminated, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystoid Macular Edema, Uveitis | Phase 2 | Status: TERMINATED